Vault-13

Privium Fund Management B.V.

AMSTERDAM, P7 · CIK 1795097 · 13F filing filed 2026-08-07

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$544.2m reported value +13.3% vs Q1 2026
61positions
61.8%in top 10
12 new 18 added 18 reduced 11 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TESLA INC COM TSLA TSLA 228,000 $95.9m17.62% 17.62% AddedShares held: Q3 2025 244.0k, Q4 2025 228.5k, Q1 2026 222.0k, Q2 2026 228.0k +6.0k +6,000 2.7%
2 SHOPIFY INC CL A SUB VTG SHS SHOP SHOP 370,000 $42.2m7.76% 7.76% ReducedShares held: Q3 2025 415.0k, Q4 2025 410.0k, Q1 2026 407.0k, Q2 2026 370.0k -37.0k -37,000 -9.1%
3 ADVANCED MICRO DEVICES INC COM AMD AMD 62,000 $36.0m6.62% 6.62% UnchangedShares held: Q3 2025 60.0k, Q4 2025 60.0k, Q1 2026 62.0k, Q2 2026 62.0k
4 AMAZON COM INC COM AMZN AMZN 140,000 $33.4m6.13% 6.13% AddedShares held: Q3 2025 149.0k, Q4 2025 121.0k, Q1 2026 125.0k, Q2 2026 140.0k +15.0k +15,000 12.0%
5 IONIS PHARMACEUTICALS INC COM IONS IONS 319,924 $25.4m4.66% 4.66% AddedShares held: Q3 2025 248.9k, Q4 2025 240.8k, Q1 2026 290.0k, Q2 2026 319.9k +29.9k +29,900 10.3%
6 SPOTIFY TECHNOLOGY S A SHS SPOT SPOT 55,000 $25.3m4.64% 4.64% ReducedShares held: Q3 2025 95.0k, Q4 2025 68.0k, Q1 2026 67.0k, Q2 2026 55.0k -12.0k -12,000 -17.9%
7 PALANTIR TECHNOLOGIES INC CL A PLTR PLTR 200,000 $23.3m4.29% 4.29% UnchangedShares held: Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 200.0k, Q2 2026 200.0k
8 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 234,222 $19.1m3.51% 3.51% ReducedShares held: Q3 2025 474.0k, Q4 2025 398.2k, Q1 2026 366.9k, Q2 2026 234.2k -132.7k -132,714 -36.2%
9 OPENDOOR TECHNOLOGIES INC COM OPEN OPEN 3,940,904 $18.2m3.35% 3.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.9m
10 LEMONADE INC COM LMND LMND 270,259 $17.6m3.23% 3.23% AddedShares held: Q3 2025 145.0k, Q4 2025 248.3k, Q1 2026 255.3k, Q2 2026 270.3k +15.0k +15,000 5.9%
11 NVIDIA CORPORATION COM NVDA NVDA 81,000 $16.2m2.98% 2.98% UnchangedShares held: Q3 2025 81.0k, Q4 2025 81.0k, Q1 2026 81.0k, Q2 2026 81.0k
12 IREN LIMITED ORDINARY SHARES IREN IREN 340,150 $15.6m2.86% 2.86% AddedShares held: Q3 2025 130.0k, Q4 2025 280.0k, Q1 2026 320.1k, Q2 2026 340.1k +20.0k +20,000 6.2%
13 UNIQURE NV SHS QURE QURE 328,322 $15.1m2.78% 2.78% ReducedShares held: Q3 2025 386.0k, Q4 2025 416.3k, Q1 2026 486.5k, Q2 2026 328.3k -158.2k -158,198 -32.5%
14 CEREBRAS SYSTEMS INC COM CL A CBRS CBRS 60,500 $13.4m2.46% 2.46% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 60.5k
15 AST SPACEMOBILE INC COM CL A ASTS ASTS 145,000 $12.9m2.37% 2.37% UnchangedShares held: Q3 2025 110.0k, Q4 2025 145.0k, Q1 2026 145.0k, Q2 2026 145.0k
16 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 338,800 $11.3m2.08% 2.08% ReducedShares held: Q3 2025 289.8k, Q4 2025 357.5k, Q1 2026 364.8k, Q2 2026 338.8k -26.0k -26,002 -7.1%
17 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 399,367 $10.5m1.92% 1.92% AddedShares held: Q3 2025 306.0k, Q4 2025 306.0k, Q1 2026 321.0k, Q2 2026 399.4k +78.4k +78,395 24.4%
18 BIOGEN INC COM BIIB BIIB 48,400 $10.5m1.92% 1.92% AddedShares held: Q3 2025 51.9k, Q4 2025 73.5k, Q1 2026 43.8k, Q2 2026 48.4k +4.6k +4,600 10.5%
19 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 5,520,024 $10.3m1.89% 1.89% AddedShares held: Q3 2025 5.0m, Q4 2025 5.4m, Q1 2026 5.5m, Q2 2026 5.5m +52.9k +52,875 1.0%
20 AXSOME THERAPEUTICS INC COM AXSM AXSM 39,944 $9.8m1.80% 1.80% ReducedShares held: Q3 2025 52.7k, Q4 2025 56.9k, Q1 2026 58.7k, Q2 2026 39.9k -18.8k -18,785 -32.0%
21 UROGEN PHARMA LTD COM URGN URGN 210,000 $7.7m1.42% 1.42% ReducedShares held: Q3 2025 196.6k, Q4 2025 214.6k, Q1 2026 238.1k, Q2 2026 210.0k -28.1k -28,122 -11.8%
22 SPACE EXPLORATION TECHN CORP CLASS A COM STK SPCX SPCX 40,000 $6.8m1.26% 1.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 40.0k
23 DENALI THERAPEUTICS INC COM DNLI DNLI 229,857 $5.9m1.09% 1.09% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 254.9k, Q2 2026 229.9k -25.0k -25,000 -9.8%
24 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 9,400 $4.7m0.86% 0.86% ReducedShares held: Q3 2025 8.3k, Q4 2025 9.4k, Q1 2026 11.4k, Q2 2026 9.4k -2.0k -1,955 -17.2%
25 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 75,000 $4.3m0.79% 0.79% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 92.3k, Q2 2026 75.0k -17.3k -17,305 -18.8%
26 KRYSTAL BIOTECH INC COM KRYS KRYS 11,170 $4.2m0.76% 0.76% UnchangedShares held: Q3 2025 12.2k, Q4 2025 12.2k, Q1 2026 11.2k, Q2 2026 11.2k
27 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 11,372 $3.4m0.63% 0.63% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 12.2k, Q2 2026 11.4k -850 -850 -7.0%
28 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 173,516 $3.2m0.59% 0.59% UnchangedShares held: Q3 2025 0, Q4 2025 173.5k, Q1 2026 173.5k, Q2 2026 173.5k
29 BIONTECH SE SPONSORED ADS BNTX BNTX 30,100 $2.8m0.51% 0.51% AddedShares held: Q3 2025 19.0k, Q4 2025 33.3k, Q1 2026 27.0k, Q2 2026 30.1k +3.1k +3,100 11.5%
30 HIMS & HERS HEALTH INC COM CL A HIMS HIMS 80,000 $2.8m0.51% 0.51% AddedShares held: Q3 2025 40.0k, Q4 2025 40.0k, Q1 2026 40.0k, Q2 2026 80.0k +40.0k +40,000 100.0%
31 MEIRAGTX HLDGS PLC COM MGTX MGTX 196,112 $2.6m0.49% 0.49% ReducedShares held: Q3 2025 163.0k, Q4 2025 200.0k, Q1 2026 212.1k, Q2 2026 196.1k -16.0k -16,000 -7.5%
32 AMBEV SA SPONSORED ADR ABEV ABEV 802,167 $2.5m0.46% 0.46% ReducedShares held: Q3 2025 897.1k, Q4 2025 1.1m, Q1 2026 948.6k, Q2 2026 802.2k -146.4k -146,391 -15.4%
33 SAREPTA THERAPEUTICS INC COM SRPT SRPT 136,500 $2.5m0.45% 0.45% AddedShares held: Q3 2025 0, Q4 2025 43.0k, Q1 2026 46.0k, Q2 2026 136.5k +90.5k +90,500 196.7%
34 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 44,974 $2.5m0.45% 0.45% AddedShares held: Q3 2025 40.0k, Q4 2025 42.9k, Q1 2026 42.9k, Q2 2026 45.0k +2.1k +2,100 4.9%
35 BEAM THERAPEUTICS INC COM BEAM BEAM 70,282 $2.4m0.44% 0.44% AddedShares held: Q3 2025 61.0k, Q4 2025 71.5k, Q1 2026 64.0k, Q2 2026 70.3k +6.3k +6,300 9.8%
36 ZAI LAB LTD ADR ZLAB ZLAB 122,189 $2.3m0.43% 0.43% ReducedShares held: Q3 2025 132.2k, Q4 2025 132.2k, Q1 2026 132.2k, Q2 2026 122.2k -10.0k -10,000 -7.6%
37 MODERNA INC COM MRNA MRNA 29,994 $2.1m0.39% 0.39% UnchangedShares held: Q3 2025 47.0k, Q4 2025 49.6k, Q1 2026 30.0k, Q2 2026 30.0k
38 CARTESIAN THERAPEUTICS INC COM NEW RNAC RNAC 151,675 $1.6m0.29% 0.29% ReducedShares held: Q3 2025 0, Q4 2025 172.5k, Q1 2026 179.1k, Q2 2026 151.7k -27.4k -27,439 -15.3%
39 MAGNUM ICE CREAM CO NV ORD SHS MICC MICC 98,221 $1.5m0.27% 0.27% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 98.2k
40 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 241,010 $1.4m0.26% 0.26% UnchangedShares held: Q3 2025 170.0k, Q4 2025 193.0k, Q1 2026 241.0k, Q2 2026 241.0k
41 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 198,900 $1.4m0.25% 0.25% AddedShares held: Q3 2025 134.9k, Q4 2025 164.9k, Q1 2026 181.9k, Q2 2026 198.9k +17.0k +17,000 9.3%
42 ZOETIS INC CL A ZTS ZTS 17,322 $1.2m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 17.3k
43 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 90,110 $1.2m0.22% 0.22% ReducedShares held: Q3 2025 197.5k, Q4 2025 210.0k, Q1 2026 170.3k, Q2 2026 90.1k -80.1k -80,146 -47.1%
44 FATE THERAPEUTICS INC COM FATE FATE 414,311 $1.1m0.21% 0.21% UnchangedShares held: Q3 2025 333.2k, Q4 2025 369.1k, Q1 2026 414.3k, Q2 2026 414.3k
45 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 35,400 $1.0m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 35.4k
46 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 244,146 $835.0k0.15% 0.15% AddedShares held: Q3 2025 432.8k, Q4 2025 170.1k, Q1 2026 242.1k, Q2 2026 244.1k +2.0k +2,000 0.8%
47 NOV INC COM NOV NOV 42,026 $779.6k0.14% 0.14% UnchangedShares held: Q3 2025 63.9k, Q4 2025 53.1k, Q1 2026 42.0k, Q2 2026 42.0k
48 B2GOLD CORP COM BTG BTG 195,083 $729.6k0.13% 0.13% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 96.5k, Q2 2026 195.1k +98.6k +98,606 102.2%
49 TOTALENERGIES SE ACT TTE TTE 10,723 $729.5k0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.7k
50 LEXEO THERAPEUTICS INC COM LXEO LXEO 155,000 $722.3k0.13% 0.13% ReducedShares held: Q3 2025 192.4k, Q4 2025 192.6k, Q1 2026 205.0k, Q2 2026 155.0k -50.0k -50,000 -24.4%
51 TRANSOCEAN LTD REGISTERED SHS RIG RIG 145,604 $712.0k0.13% 0.13% AddedShares held: Q3 2025 102.0k, Q4 2025 139.6k, Q1 2026 106.6k, Q2 2026 145.6k +39.0k +39,000 36.6%
52 MOLINA HEALTHCARE INC COM MOH MOH 2,979 $681.3k0.13% 0.13% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 8.1k, Q2 2026 3.0k -5.2k -5,161 -63.4%
53 NU HLDGS LTD ORD SHS CL A NU NU 44,000 $587.8k0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 44.0k
54 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 363,430 $581.5k0.11% 0.11% UnchangedShares held: Q3 2025 308.8k, Q4 2025 326.2k, Q1 2026 363.4k, Q2 2026 363.4k
55 TIDEWATER INC NEW COM TDW TDW 8,683 $578.5k0.11% 0.11% AddedShares held: Q3 2025 5.5k, Q4 2025 5.5k, Q1 2026 5.5k, Q2 2026 8.7k +3.2k +3,200 58.4%
56 LULULEMON ATHLETICA INC COM LULU LULU 5,063 $578.1k0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.1k
57 SANDRIDGE ENERGY INC COM NEW SD SD 38,792 $531.5k0.10% 0.10% UnchangedShares held: Q3 2025 50.4k, Q4 2025 38.8k, Q1 2026 38.8k, Q2 2026 38.8k
58 SEABRIDGE GOLD INC COM SA SA 16,512 $425.0k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 16.5k
59 VOYAGER THERAPEUTICS INC COM VYGR VYGR 120,000 $420.0k0.08% 0.08% UnchangedShares held: Q3 2025 45.0k, Q4 2025 95.0k, Q1 2026 120.0k, Q2 2026 120.0k
60 ENGENE THERAPEUTICS INC COM ENGN ENGN 170,000 $294.1k0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 170.0k
61 COSAN S A ADS CSANY CSANY 52,000 $149.8k0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 52.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
COINBASE GLOBAL INC COIN COIN 79,000 $13.8m79.0k shares
SEA LTD SE SE 138,000 $11.4m138.0k shares
ESPERION THERAPEUTICS INC NE ESPR ESPR 3,299,441 $9.0m3.3m shares
ENGENE HOLDINGS INC 352,087 $2.4m352.1k shares
STOKE THERAPEUTICS INC STOK STOK 50,000 $1.6m50.0k shares
PFIZER INC PFE PFE 52,679 $1.5m52.7k shares
SCHLUMBERGER LTD SLB SLB 18,451 $948.2k18.5k shares
SEABRIDGE GOLD INC 24,828 $703.6k24.8k shares
NOBLE CORP PLC NE NE 6,849 $336.1k6.8k shares
PAN AMERN SILVER CORP PAAS PAAS 3,900 $213.1k3.9k shares
SPROTT FDS TR URNM URNM 3,302 $208.5k3.3k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROQR THRAPEUTICS N V PRQR · 13G · filed 2026-07-15 PRQR 5.2%≈ $10.3m no change 13G 2026-07-15